Your browser doesn't support javascript.
loading
Validation of the revised international prognostic scoring system (IPSS-R) in patients with myelodysplastic syndrome: a multicenter study.
Neukirchen, Judith; Lauseker, Michael; Blum, Sabine; Giagounidis, Aristoteles; Lübbert, Michael; Martino, Samuela; Siragusa, Sergio; Schlenk, Richard F; Platzbecker, Uwe; Hofmann, Wolf-Karsten; Götze, Katharina; Palumbo, Giuseppe A; Magrin, Silvana; Kündgen, Andrea; Aul, Carlo; Hildebrandt, Barbara; Hasford, Joerg; Kobbe, Guido; Haas, Rainer; Germing, Ulrich.
Affiliation
  • Neukirchen J; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany. Electronic address: Judith.Neukirchen@med.uni-duesseldorf.de.
  • Lauseker M; Institute for Medical Information Sciences, Biometry and Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany.
  • Blum S; Department of Hematology, University Lausanne, Switzerland.
  • Giagounidis A; Department of Hematology, Oncology and Clinical Immunology, St. Johannes Hospital, Duisburg, Germany.
  • Lübbert M; Department of Hematology and Oncology, Albert-Ludwigs-University, Freiburg, Germany.
  • Martino S; Department of Hematology, University of Palermo, Italy.
  • Siragusa S; Department of Hematology, University of Palermo, Italy.
  • Schlenk RF; Department of Internal Medicine III, University Hospital Ulm, Germany.
  • Platzbecker U; Department of Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Hofmann WK; Department of Medicine III, University Hospital Mannheim, Germany.
  • Götze K; Department of Medicine III, Division for Hematology and Oncology, Klinikum rechts der Isar, Technical University, Munich, Germany.
  • Palumbo GA; Department of Hematology, AOU "Policlinico - V. Emanuele", Catania, Italy.
  • Magrin S; Division of Hematology and BMT Unit, V. Cervello Hospital, Palermo, Italy.
  • Kündgen A; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.
  • Aul C; Department of Hematology, Oncology and Clinical Immunology, St. Johannes Hospital, Duisburg, Germany.
  • Hildebrandt B; Department of Human Genetics, Heinrich-Heine-University, Düsseldorf, Germany.
  • Hasford J; Institute for Medical Information Sciences, Biometry and Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany.
  • Kobbe G; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.
  • Haas R; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.
  • Germing U; Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.
Leuk Res ; 38(1): 57-64, 2014 Jan.
Article in En | MEDLINE | ID: mdl-24238640
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid / Risk Assessment Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid / Risk Assessment Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leuk Res Year: 2014 Type: Article